Jerry Lanchbury, chief scientific officer, joined Myriad Genetics in September 2002. Before that he was a researcher in molecular immunogenetics at Kings College London. Dr. Lanchbury graduated from the University of Aston, Birmingham, U.K. He earned his Ph.D. in Human Population Genetics from the University of Newcastle upon Tyne. Jerry led the teams that developed several of Myriad’s molecular diagnostic tests and is active across all five of Myriad’s business units, namely Women’s Health, Oncology, Neurosciences, Autoimmune and Myriad RBM.